Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
Public ClinicalTrials.gov record NCT00501293. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIIb, Long-Term, Open-Label, Multi-Center, Extension Study Designed to Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the long-term, safety of Methylphenidate Transdermal System (MTS) in aged 13-17 years diagnosed withADHD
Study identification
- NCT ID
- NCT00501293
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 163 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 13 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- Jan 31, 2009
- Completion
- Jan 31, 2009
- Last update posted
- Apr 25, 2017
2007 – 2009
United States locations
- U.S. sites
- 32
- U.S. states
- 20
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Melmed Center | Scottsdale | Arizona | — | — |
| Bay Area Research Institute | Lafayette | California | — | — |
| Elite Clinical Trials Inc. | Wildomar | California | — | — |
| Sarkis Clinical Trials | Gainsville | Florida | — | — |
| Miami Research Associates | South Miami | Florida | — | — |
| Northwest Behavioral Research Ctr | Roswell | Georgia | — | — |
| Mountain West Clinical Trials, LLC | Eagle | Idaho | — | — |
| Vince and Associates Clinical Research | Overland Park | Kansas | — | — |
| Shire Clinical Research Site | Lexington | Kentucky | — | — |
| Four Rivers Clinical Research, Inc. | Paducah | Kentucky | — | — |
| Rochester Center for Behavioral Medicine | Rochester Hills | Michigan | — | — |
| Clinical Neurophysiology Services, PC | Troy | Michigan | — | — |
| CRI Worldwide | Clementon | New Jersey | — | — |
| Triangle Neuropsychiatry | Durham | North Carolina | — | — |
| Dakota Clinic/Innovis Health | Fargo | North Dakota | — | — |
| Odyssey Research | Minot | North Dakota | — | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | — | — |
| Oregon center for Clinical Investigations, Inc. | Eugene | Oregon | — | — |
| OCCI, Inc | Portland | Oregon | — | — |
| Shire Clinical Research Site | Media | Pennsylvania | — | — |
| CRI Worldwide | Philadelphia | Pennsylvania | — | — |
| Rhode Island Hospital | Providence | Rhode Island | — | — |
| CNS Healthcare | Memphis | Tennessee | — | — |
| FutureSearch Trials | Austin | Texas | — | — |
| Claghorn-Lesem Research, Ltd. | Bellaire | Texas | — | — |
| Westex Clinical Investigations | Lubbock | Texas | — | — |
| Cerebral Research, LLC | San Antonio | Texas | — | — |
| Vermont Clinical Study Center | Burlington | Vermont | — | — |
| NeuroScience, Inc. | Herndon | Virginia | — | — |
| Adolescent Health Center | Midlothian | Virginia | — | — |
| Northwest Clinical Research Center | Friday Harbor | Washington | — | — |
| Eastside Therapeutic Resource | Kirkland | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00501293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 25, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00501293 live on ClinicalTrials.gov.